Methyldopa

General description Pharmaceutical secondary standards for application in quality control provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards Application

Application 3- O -Methylmethyldopa USP reference standard, intended for use in specified quality tests and assays as specified in the USP compendia. Analysis Note These products are for test and assay use only.

L-α-methyldopa.

L-α-methyldopa.

DescriptionL-Dopa-(phenyl-d3) or (3-(3,4-dihydroxyphenyl-2,5,6-d3)-L-alanine) can be used as an internal standard for the quantification of methyldopa in human plasma by LC-MS-MS based method.

MEDICATION FORCEPS MERIAM, 16 CM Made in Germany Cross-reference Hu-Friedy DP318

Methyldopate is an ethyl ester proagent of α-Methyldopa (α-MD). Methyldopa (L-(-)-α-Methyldopa) is an α-adrenergic agonist (selective for α2-adrenergic receptors).

Methyldopate is an ethyl ester proagent of α-Methyldopa (α-MD). Methyldopa (L-(-)-α-Methyldopa) is an α-adrenergic agonist (selective for α2-adrenergic receptors). Methyldopate has the potential for severe hypertension research。.

Methyldopate is an ethyl ester proagent of α-Methyldopa (α-MD). Methyldopa (L-(-)-α-Methyldopa) is an α-adrenergic agonist (selective for α2-adrenergic receptors). Methyldopate has the potential for severe hypertension research。.

Methyldopate is an ethyl ester proagent of α-Methyldopa (α-MD). Methyldopa (L-(-)-α-Methyldopa) is an α-adrenergic agonist (selective for α2-adrenergic receptors). Methyldopate has the potential for severe hypertension research。.

Methyldopate is an ethyl ester proagent of α-Methyldopa (α-MD). Methyldopa (L-(-)-α-Methyldopa) is an α-adrenergic agonist (selective for α2-adrenergic receptors). Methyldopate has the potential for severe hypertension research。.

Methyldopate is an ethyl ester proagent of α-Methyldopa (α-MD). Methyldopa (L-(-)-α-Methyldopa) is an α-adrenergic agonist (selective for α2-adrenergic receptors). Methyldopate has the potential for severe hypertension research。.